http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108484738-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-255 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 |
filingDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108484738-B |
titleOfInvention | Radiation-resistant peptide mutant protein and preparation and purification method thereof |
abstract | The invention discloses a preparation and purification method of a radioresistance peptide or a mutant protein thereof, which can obviously improve the purity of the protein and is convenient for industrial production. The invention also provides a radiation-resistant peptide mutant protein, which is characterized in that an amino acid sequence between ND1 and CD1 structural domains is replaced on the basis of the radiation-resistant peptide protein CBLB502, the mutant protein has an amino acid sequence shown in SEQ ID NO. 2, and the stability of the mutant protein is obviously superior to that of the CBLB502 protein in the prior art. |
priorityDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.